Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection.
Publication
, Journal Article
Clark, PJ; Thompson, AJV; McHutchison, JG
Published in: Clin Pharmacol Ther
November 2010
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development. For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers,and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
Duke Scholars
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
November 2010
Volume
88
Issue
5
Start / End Page
708 / 711
Location
United States
Related Subject Headings
- Translational Research, Biomedical
- Polymorphism, Single Nucleotide
- Phenotype
- Pharmacology & Pharmacy
- Interleukins
- Interferons
- Humans
- Hepatitis C, Chronic
- Genotype
- Drug Discovery
Citation
APA
Chicago
ICMJE
MLA
NLM
Clark, P. J., Thompson, A. J. V., & McHutchison, J. G. (2010). Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection. Clin Pharmacol Ther, 88(5), 708–711. https://doi.org/10.1038/clpt.2010.185
Clark, P. J., A. J. V. Thompson, and J. G. McHutchison. “Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection.” Clin Pharmacol Ther 88, no. 5 (November 2010): 708–11. https://doi.org/10.1038/clpt.2010.185.
Clark PJ, Thompson AJV, McHutchison JG. Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection. Clin Pharmacol Ther. 2010 Nov;88(5):708–11.
Clark, P. J., et al. “Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection.” Clin Pharmacol Ther, vol. 88, no. 5, Nov. 2010, pp. 708–11. Pubmed, doi:10.1038/clpt.2010.185.
Clark PJ, Thompson AJV, McHutchison JG. Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection. Clin Pharmacol Ther. 2010 Nov;88(5):708–711.
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
November 2010
Volume
88
Issue
5
Start / End Page
708 / 711
Location
United States
Related Subject Headings
- Translational Research, Biomedical
- Polymorphism, Single Nucleotide
- Phenotype
- Pharmacology & Pharmacy
- Interleukins
- Interferons
- Humans
- Hepatitis C, Chronic
- Genotype
- Drug Discovery